Evidence map›Paper›PMID 32652570›Full record

ArticleThe Journal of pathology2020

Molecular and functional characterization of urine-derived podocytes from patients with Alport syndrome.

Corinne Iampietro, Linda Bellucci, Fanny O Arcolino, Maddalena Arigoni, Luca Alessandri, Yonathan Gomez, Elli Papadimitriou, Raffaele A Calogero, Enrico Cocchi, Lambertus Van Den Heuvel and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Organs-on-chip technology: a tool to tackle genetic kidney diseases.Pediatric nephrology (Berlin, Germany) · 2022
    Review
  9. Sourcing cells forFrontiers in medical technology · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Corinne IampietroDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Linda BellucciDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Fanny O ArcolinoLaboratory of Pediatric Nephrology, Department of Development & Regeneration, University of Leuven, Leuven, Belgium.
Maddalena ArigoniDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Luca AlessandriDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Yonathan GomezDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Elli PapadimitriouDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Raffaele A CalogeroDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Enrico CocchiDepartment of Pediatric Nephrology, University of Torino, Torino, Italy.
Lambertus Van Den HeuvelLaboratory of Pediatric Nephrology, Department of Development & Regeneration, University of Leuven, Leuven, Belgium.
Elena LevtchenkoLaboratory of Pediatric Nephrology, Department of Development & Regeneration, University of Leuven, Leuven, Belgium.
Benedetta BussolatiDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.ORCID 0000-0002-3663-5134
University of Turin · ITKU Leuven · BE5T Torino (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alport syndrome (AS) is a genetic disorder involving mutations in the genes encoding collagen IV α3, α4 or α5 chains, resulting in the impairment of glomerular basement membrane. Podocytes are responsible for production and correct assembly of collagen IV isoforms; however, data on the phenotypic characteristics of human AS podocytes and their functional alterations are currently limited. The evident loss of viable podocytes into the urine of patients with active glomerular disease enables their isolation in a non-invasive way. Here we isolated, immortalized, and subcloned podocytes from the urine of three different AS patients for molecular and functional characterization. AS podocytes expressed a typical podocyte signature and showed a collagen IV profile reflecting each patient's mutation. Furthermore, RNA-sequencing analysis revealed 348 genes differentially expressed in AS podocytes compared with control podocytes. Gene Ontology analysis underlined the enrichment in genes involved in cell motility, adhesion, survival, and angiogenesis. In parallel, AS podocytes displayed reduced motility. Finally, a functional permeability assay, using a podocyte-glomerular endothelial cell co-culture system, was established and AS podocyte co-cultures showed a significantly higher permeability of albumin compared to control podocyte co-cultures, in both static and dynamic conditions under continuous perfusion. In conclusion, our data provide a molecular characterization of immortalized AS podocytes, highlighting alterations in several biological processes related to extracellular matrix remodelling. Moreover, we have established an in vitro model to reproduce the altered podocyte permeability observed in patients with AS. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland..

Indexed as

AdolescentChildCollagen Type IVEndothelial CellsFemaleGlomerular Basement MembraneHumansMaleMutationNephritis, HereditaryPodocytesYoung AdultCollagen Type IVAlport syndromeco-culturecollagen IVgenetic defectsglomerular endothelial cellspermeabilityurine-derived podocytes

Identifiers

PMID32652570
PMCPMC7589231
OpenAlexW3042013568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.